Overview

Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Validation of the exendin-based beta cell imaging technique in patients with type 2 diabetes
Phase:
N/A
Details
Lead Sponsor:
Radboud University
Collaborator:
University of Coimbra
Treatments:
Exenatide